Quinalizarin induces cycle arrest and apoptosis via reactive oxygen species-mediated signaling pathways in human melanoma A375 cells.

Drug Dev Res 2019 12 20;80(8):1040-1050. Epub 2019 Aug 20.

Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang, China.

Quinalizarin, a bioactive and highly selective compound, is known to promote apoptosis in colon and lung cancer cells. However, studies evaluating quinalizarin-induced apoptosis in melanoma cells have not been conducted. In the present study, we investigated the underlying mechanisms of antimelanoma activity of quinalizarin in human melanoma A375 cells. The MTT assay and Trypan blue staining were used to evaluate the cell viability. The flow cytometry was used to detect cell cycle, apoptosis and reactive oxygen species (ROS). Western blot was used to detect the expression of cell cycle and apoptosis-related proteins, MAPK, and STAT3. The results revealed a significant dose and time dependent effect of quinalizarin on inhibiting proliferation in three kinds of human melanoma cells, and had no significant toxic effects on normal cells. Moreover, quinalizarin triggered G2/M phase cell arrest by modulating the protein expression levels of CDK 1/2, cyclin A, cyclin B, p21 and p27, and induced apoptosis by down-regulating the antiapoptotic protein Bcl-2 and upregulating the proapoptotic protein BAD, leading to the activation of caspase-3 and PARP in the caspase cascade in A375 cells. Quinalizarin treatment led to apoptosis of A375 cells via activation of MAPK and inhibition of STAT3 signaling pathways. In addition, quinalizarin increased the level of ROS, but ROS scavenger NAC inhibited quinalizarin-induced apoptosis by regulating MAPK and STAT3 signaling pathways. In summary, quinalizarin induces cell cycle arrest and apoptosis via ROS-mediated MAPK and STAT3 signaling pathways in human melanoma A375 cells, and quinalizarin may be used as a novel and effective antimelanoma therapeutic.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ddr.21582DOI Listing
December 2019
0.734 Impact Factor

Publication Analysis

Top Keywords

a375 cells
20
signaling pathways
16
human melanoma
16
cells quinalizarin
16
melanoma a375
12
stat3 signaling
12
mapk stat3
12
cell cycle
12
cells
9
quinalizarin
9
pathways human
8
melanoma cells
8
quinalizarin-induced apoptosis
8
apoptosis reactive
8
quinalizarin induces
8
arrest apoptosis
8
cycle arrest
8
reactive oxygen
8
apoptosis
8
cell
5

References

(Supplied by CrossRef)
Caspase control: Protagonists of cancer cell apoptosis
Fiandalo M. V. et al.
Experimental Oncology 2012
DYRK1A kinase inhibitors with emphasis on
Ionescu A. et al.
Cancer. Mini Reviews in Medicinal Chemistry 2012

Similar Publications